|
Aug 6
|
Basic Materials Roundup: Market Talk
|
|
Aug 6
|
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
|
|
Aug 6
|
Bayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View
|
|
Aug 6
|
Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?
|
|
Aug 6
|
[Latest] Global Lawn and Garden Consumables Market Size/Share Worth USD 38 Billion by 2034 at a 4.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Aug 6
|
India's Bayer CropScience posts higher quarterly profit on strong herbicide, corn seed demand
|
|
Aug 6
|
Bayer investors concerned soccer transfers inflated earnings, shares drop
|
|
Aug 5
|
KRYS Q2 Earnings and Sales Top Estimates, Stock Down on Q3 Outlook
|
|
Aug 4
|
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
|
|
Aug 4
|
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
|
|
Aug 1
|
Regeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales Up
|
|
Aug 1
|
Bayer sets aside more cash to deal with weedkiller woes
|
|
Aug 1
|
Regeneron posts better-than-expected Q2 results, downplays tariff impact
|
|
Jul 31
|
Bayer Ups Guidance After Pharmaceuticals Unit Outperforms
|
|
Jul 31
|
Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
|
|
Jul 31
|
Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
|
|
Jul 29
|
INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales
|
|
Jul 29
|
Chondrosarcoma Market Report 2025-2035: Increased Research on Rare Skeletal Tumors and IDH1/2 Mutation-targeted Therapies
|
|
Jul 25
|
Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause
|
|
Jul 24
|
Do Q2 Reports Shape a More Uncertain Outlook?
|